CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
31.05 0.15(0.49%) NAV as on 25 Nov 2025
-0.32 % 1 M
0.45 % 1 Y
20.74 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.31

As on 31 Oct, 2025
age-icon Age :

6 yrs 4 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

847.28 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Others 3.26 %
Equity 96.74 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.60 %
Apollo Hospitals Enterprise Ltd.7.70 %
Cipla Ltd.6.68 %
Fortis Healthcare Ltd.4.56 %
Lupin Ltd.4.55 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs72.38
Hospital & Healthcare Services21.68
Business Support1.76
Chemicals0.92
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)16.1218.2216.3626.4529.39
Net Assets(Rs Crores) (as on 31-Mar-2025) 454.91 515.33 428.44 699.55 814.95
Scheme Returns(%)(Absolute)63.4912.40-10.2661.3810.03
B'mark Returns(%)(Absolute)NANANANANA
Category Rank55/7549/7570/7611/9032/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity31.050.15(0.49%)NAV As on 26 Nov, 202510-Jul-2019Inception Date847.28AUM In Cr.0.45%1Y20.74%3Y15.41%5Y19.42%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity40.510.40(1.00%)NAV As on 26 Nov, 202513-Jul-2018Inception Date6,437.36AUM In Cr.6.83%1Y27.32%3Y20.05%5Y20.88%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity431.47-0.01(0.00%)NAV As on 26 Nov, 202514-Jul-1999Inception Date4,082.13AUM In Cr.1.87%1Y23.84%3Y18.88%5Y16.06%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.840.17(0.54%)NAV As on 26 Nov, 202528-Dec-2015Inception Date1,324.90AUM In Cr.2.94%1Y21.96%3Y17.17%5Y12.02%Since Inception
Nippon India Pharma Fund(G)Very HighEquity518.743.97(0.77%)NAV As on 26 Nov, 202505-Jun-2004Inception Date8,346.49AUM In Cr.2.44%1Y21.64%3Y17.12%5Y20.17%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors